The dramatic increase in NK cells and CD8+ T cell subsets with functional cytotoxic and proliferating gene expression signatures explained the promising tumor eradication efficacy by V-Navo@gel treatment in the subcutaneous HCC mouse model. The gene discussed is CD8A; the disease is hepatocellular carcinoma.